Yumi Takimoto
Papers
1
Total Citations
4
H-Index
1
About
Dr. Yumi Takimoto is a leading clinical researcher at the intersection of gynecologic oncology and bariatric medicine, whose work addresses the critical challenge of managing endometrial cancer and atypical endometrial hyperplasia in severely obese patients. Her most cited study, "Weight-Loss Interventions and Levonorgestrel Intrauterine System Implantation for Early-Stage Endometrial Cancer and Atypical Endometrial Hyperplasia to Reduce Perioperative Risk of Severely Obese Patients" (2023), pioneers a novel preoperative protocol that combines hormonal therapy with structured weight-loss interventions. This approach aims to reduce perioperative morbidity and surgical complexity in laparoscopic and robotic procedures, while carefully balancing the risks of delayed surgery. Dr. Takimoto’s research has garnered significant attention for its practical, patient-centered framework, offering a safer pathway for a high-risk population. By integrating fertility-sparing hormonal treatment with aggressive weight management, she has opened new avenues for personalized care in early-stage disease. Her work not only advances surgical safety but also underscores the importance of multidisciplinary collaboration in oncology, making her a vital voice in the evolving landscape of gynecologic cancer treatment.
Research Focus
Key Achievements
Top Papers
- 1